Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

SB-399885

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
SB-399885
Identifiers
  • N-(3,5-Dichloro-2-methoxyphenyl)-4-methoxy-3-(1-piperazinyl)benzenesulfonamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC18H21Cl2N3O4S
Molar mass446.34 g·mol−1
3D model (JSmol)
  • C3CNCCN3c2cc(ccc2OC)S(=O)(=O)Nc(c1OC)cc(Cl)cc1Cl
  • InChI=1S/C18H21Cl2N3O4S/c1-26-17-4-3-13(11-16(17)23-7-5-21-6-8-23)28(24,25)22-15-10-12(19)9-14(20)18(15)27-2/h3-4,9-11,21-22H,5-8H2,1-2H3
  • Key:ATKZKAYWARYLBW-UHFFFAOYSA-N
 ☒NcheckY (what is this?)  (verify)

SB-399885 is a drug which is used in scientific research. It acts as a potent, selective and orally active5-HT6receptorantagonist, with aKi of 9.0nM. SB-399885 and other 5-HT6 antagonists shownootropic effects in animal studies,[1][2] as well asantidepressant andanxiolytic effects which are comparable to and synergistic with drugs such asimipramine anddiazepam,[3][4][5] and have been proposed as potential novel treatments for cognitive disorders such asschizophrenia[6] andAlzheimer's disease.

References

[edit]
  1. ^Perez-García G, Meneses A (July 2005). "Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task".Pharmacology, Biochemistry, and Behavior.81 (3):673–82.doi:10.1016/j.pbb.2005.05.005.PMID 15964617.S2CID 19789219.
  2. ^Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, et al. (December 2006). "SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models".European Journal of Pharmacology.553 (1–3):109–19.doi:10.1016/j.ejphar.2006.09.049.PMID 17069795.
  3. ^Wesołowska A, Nikiforuk A (April 2007). "Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression".Neuropharmacology.52 (5):1274–83.doi:10.1016/j.neuropharm.2007.01.007.PMID 17320917.S2CID 22664564.
  4. ^Wesołowska A (February 2008). "The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors".European Journal of Pharmacology.580 (3):355–60.doi:10.1016/j.ejphar.2007.11.022.PMID 18096153.
  5. ^Wesołowska A, Nikiforuk A (March 2008). "The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats".European Journal of Pharmacology.582 (1–3):88–93.doi:10.1016/j.ejphar.2007.12.013.PMID 18234190.
  6. ^Li Z, Huang M, Prus AJ, Dai J, Meltzer HY (February 2007). "5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus".Brain Research.1134 (1):70–8.doi:10.1016/j.brainres.2006.11.060.PMID 17207474.S2CID 21162681.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenylpiperazines
Benzylpiperazines
Naphthylpiperazines
Quinolinylpiperazines
Diphenylalkylpiperazines
Pyrimidinylpiperazines
Pyridinylpiperazines
Benzo(iso)thiazolylpiperazines
Tricyclic-linked piperazines
Others/uncategorized
Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=SB-399885&oldid=1270872869"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp